Status:
RECRUITING
Omegapres Versus Solifenacin and Mirabegron Combination Therapy in Treatment of Primary MNE
Lead Sponsor:
Mansoura University
Conditions:
Nocturnal Enuresis in Children
Eligibility:
All Genders
6-18 years
Phase:
PHASE3
Brief Summary
The goal of this clinical trial is to compare combination of Solifenacin and MIrabegron in treatment of primary mono-symptomatic nocturnal enuresis in children. It will also learn about the safety of ...
Detailed Description
Nocturnal enuresis (NE) is defined as intermittent incontinence during sleep in a child aged 5 years or more in the absence of congenital anomalies of the urinary tract or congenital or acquired defec...
Eligibility Criteria
Inclusion
- Primary mono-symptomatic nocturnal enuresis -
Exclusion
- Bowel dysfunction Psychatric illness Respiratory sleep disorders
- \-
Key Trial Info
Start Date :
December 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07199894
Start Date
December 1 2024
End Date
February 1 2026
Last Update
September 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt